Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system.
about
A Raman-based endoscopic strategy for multiplexed molecular imaging.The big picture on nanomedicine: the state of investigational and approved nanomedicine productsEffect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitroFacile Attachment of TAT Peptide on Gold Monolayer Protected Clusters: Synthesis and CharacterizationClinical Translation of Nanomedicine.Guidable Thermophoretic Janus Micromotors Containing Gold Nanocolorifiers for Infrared Laser Assisted Tissue Welding.PHOTOACOUSTIC IMAGING FOR MEDICAL DIAGNOSTICS.Photothermal nanodrugs: potential of TNF-gold nanospheres for cancer theranostics.Advances in Clinical and Biomedical Applications of Photoacoustic Imaging.Multiplex photoacoustic molecular imaging using targeted silica-coated gold nanorodsPreclinical evaluation of Raman nanoparticle biodistribution for their potential use in clinical endoscopy imaging.Nanotechnology in head and neck cancer: the race is on.Delivery of antiviral small interfering RNA with gold nanoparticles inhibits dengue virus infection in vitro.Protein corona composition does not accurately predict hematocompatibility of colloidal gold nanoparticles.Thermophysical and biological responses of gold nanoparticle laser heating.Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications.Nanoparticle-based theranostic agentsRefilling drug delivery depots through the blood.Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicineGold nanoparticles in radiation research: potential applications for imaging and radiosensitization.In vivo study of spherical gold nanoparticles: inflammatory effects and distribution in mice.Selective targeting of brain tumors with gold nanoparticle-induced radiosensitizationNanoparticle preconditioning for enhanced thermal therapies in cancerLow-dose gold nanoparticles exert subtle endocrine-modulating effects on the ovarian steroidogenic pathway ex vivo independent of oxidative stress.Gene Therapies for Cancer: Strategies, Challenges and Successes.Nanotechnology for energy-based cancer therapiesBiodistribution and in vivo toxicity of aptamer-loaded gold nanostars.Ligand-targeted theranostic nanomedicines against cancerMislocalization of death receptors correlates with cellular resistance to their cognate ligands in human breast cancer cellsProbabilistic modelling of prospective environmental concentrations of gold nanoparticles from medical applications as a basis for risk assessmentBlood-nanoparticle interactions and in vivo biodistribution: impact of surface PEG and ligand properties.Combination of Gold Nanoparticle-Conjugated Tumor Necrosis Factor-α and Radiation Therapy Results in a Synergistic Antitumor Response in Murine Carcinoma Models.Biodistribution, Clearance, and Toxicology of Polymeric Micelles Loaded with 0.9 or 5 nm Gold NanoparticlesFunctionalized gold nanoparticles for the binding, stabilization, and delivery of therapeutic DNA, RNA, and other biological macromoleculesApplications of nanoparticles in the detection and treatment of kidney diseasesGold nanocage-photosensitizer conjugates for dual-modal image-guided enhanced photodynamic therapy.Gold nanoparticle mediated cancer immunotherapyFe3O4 nanoparticles and cryoablation enhance ice crystal formation to improve the efficiency of killing breast cancer cellsBiodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies.Inorganic nanoparticles in cancer therapy.
P2860
Q24609293-C51AE66C-A622-444C-8725-BFB9E800D9A3Q27021817-17EBA713-7A9D-4C51-BEAA-1B75FE6A10FFQ28385413-436A0BF3-A246-43DF-B984-5834C159939CQ29248762-36AABE0D-3B59-4E5A-A8DB-74209A78124BQ30355939-D7378B60-2465-4438-9BB1-10E5E54E9399Q30396527-A5BDC607-D917-42B5-8597-C3BC767EA729Q30448532-57565965-7343-481C-9FFB-8CB935DEE2A7Q30457900-2118AE56-214C-4D13-97C5-EE4BB2728C43Q30473259-BA66FA98-E7A3-4DF0-AAFF-C8169C76E2DEQ30474840-6B0CC03E-721B-4E2D-8345-5FDBE7E351BDQ30586800-AAA722EB-962B-4597-B639-E755F8D15C50Q33742598-F5A9DA04-E314-43A3-ADB1-020FBF40680CQ33918636-9EDAE676-70F5-4649-B454-FA59541CA68AQ34017288-21DE6141-BB29-4ED9-B4D2-75ADA7C83A85Q34030504-53EB563C-A2E3-4C5D-A91D-B96D6801B185Q34076571-D9B641F7-5542-4608-BA38-E8DE7C58F0FEQ34130095-313CB86A-1DCC-4AF2-AA7D-2AFAD9E268DEQ34144515-A8F67DC0-2111-4C15-8D8E-BAB6BAB0E853Q34419681-C11ADD19-C432-4FC5-95DA-023000883450Q34563668-ED87A6E1-DC3D-4CDA-9C92-CCACECC37990Q34612876-F45A4F88-56E1-4FF2-A8CC-A2C901313F65Q34701455-452D6FBC-A0E0-4F29-9F35-DC3A29DF4664Q34987068-D6D120F9-0474-4E84-B192-CE5F8B3916E0Q35122072-B86EA341-50C3-48EB-A782-401902AE5728Q35186312-F3B24E7C-248A-4522-BEA5-469CCEAD99FAQ35264028-13DF8DA3-0D25-45F4-A69D-3EB21A75E95AQ35268464-6B827368-D048-454C-87C1-803F3FDCC4F8Q35895637-371A31BB-89BF-47C9-821B-172A933440CDQ36339240-A7114AB8-6C97-4B7F-819C-487AB076AF22Q36398030-2AA5133D-6802-4295-AC25-CF918CE2C6D5Q36472643-6E5EE3DE-D169-4AFB-99B7-A2A966EB1828Q37068894-952F2C6F-28CB-4D00-A2E0-DB66C4447189Q37088530-619986CD-0647-458E-9758-0A82E35E3181Q37194010-2AA3F6EF-C707-42C9-AADB-E2F95A59D92EQ37298541-49F425BE-CE12-4F33-8DB6-5DF09B8CEE45Q37511124-EC83F953-A2E6-486F-A226-55DFA7CC2E2BQ37666077-21AC1F43-F555-499E-8284-BEA2127B89F5Q37706919-8B0DC591-EAAD-49BF-8DBF-B74435EEF5B1Q37809976-AE94F878-2D9E-45E3-8A7F-0981D35F8ED6Q37812005-4383E2E0-2FE8-4CC0-86CF-33ABDEC26EA1
P2860
Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system.
@en
Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system.
@nl
type
label
Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system.
@en
Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system.
@nl
prefLabel
Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system.
@en
Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system.
@nl
P2093
P2860
P356
P1433
P1476
Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system.
@en
P2093
Giulio F Paciotti
John C Bischof
Rachana Visaria
Raghav Goel
P2860
P304
P356
10.2217/NNM.09.21
P577
2009-06-01T00:00:00Z